Q: What is the primary mechanism of action of macrocyclic lactones against filarial worms?
a. Inhibition of acetylcholinesterase
b. Blockade of voltage-gated sodium channels
c. Suppression of excretory-secretory (ES) protein excretion
d. Disruption of microtubule formation
e. Inhibition of DNA synthesis
A: c. Suppression of excretory-secretory (ES) protein excretion. The text states that macrocyclic lactones suppress the excretion of ES proteins in filarial worms, which interferes with the host complement cascade.

Q: Which of the following best describes the effect of macrocyclic lactones on adult heartworms versus immature forms?
a. Equally effective against all life stages
b. More effective against adults than immature forms
c. Effective against adults but not immature forms
d. Effective against immature forms but minimal effect on adults
e. No effect on any life stage of heartworms
A: d. Effective against immature forms but minimal effect on adults. The text mentions that macrocyclic lactones are very effective against immature forms like microfilariae and L3 of heartworms, but have minimal effect on adult heartworms.

Q: What unique property of eprinomectin allows its use in lactating dairy cattle?
a. Rapid elimination from the body
b. Low toxicity to mammals
c. Partitioning away from milk
d. High efficacy against all parasites
e. Ability to cross the blood-brain barrier
A: c. Partitioning away from milk. The text states that eprinomectin is the only macrolide that can be used in lactating dairy cattle because it partitions away from milk.

Q: Which macrocyclic lactone is FDA-approved for use as a 6-month injectable heartworm preventative in dogs?
a. Ivermectin
b. Selamectin
c. Moxidectin
d. Milbemycin oxime
e. Doramectin
A: c. Moxidectin. The text mentions PROHEART 6, a sustained-release formulation of moxidectin, approved for 6-month prevention of heartworms in dogs.

Q: What is the primary concern with using macrocyclic lactones in Collies and related breeds?
a. Inefficacy against parasites
b. Increased risk of toxicity due to MDR1 mutation
c. Rapid drug metabolism
d. Allergic reactions
e. Gastrointestinal side effects
A: b. Increased risk of toxicity due to MDR1 mutation. The text discusses the MDR1 mutation in Collies and related breeds, which makes them unusually sensitive to macrocyclic lactones and increases the risk of toxicity.

Q: Which macrocyclic lactone is uniquely effective against encysted small strongyles in horses?
a. Ivermectin
b. Doramectin
c. Moxidectin
d. Eprinomectin
e. Selamectin
A: c. Moxidectin. The text states that moxidectin is particularly effective against encysted small strongyles in horses and is labeled to suppress strongyle egg production through 84 days.

Q: What is the FDA-approved dose of ivermectin for heartworm prevention in dogs?
a. 0.006 mg/kg monthly
b. 0.024 mg/kg monthly
c. 0.05 mg/kg monthly
d. 0.1 mg/kg monthly
e. 0.2 mg/kg monthly
A: a. 0.006 mg/kg monthly. The text specifies that ivermectin tablets for dogs are administered at 0.006 mg (6 mcg) per kilogram monthly to prevent heartworm establishment.

Q: Which of the following is NOT a concern regarding the environmental impact of macrocyclic lactones?
a. Toxicity to aquatic animals
b. Harm to dung-feeding insects
c. Delayed processing of nutrients in dung
d. Toxicity to birds
e. Effects on larval instars of invertebrates
A: d. Toxicity to birds. The text mentions that macrocyclic lactones are toxic to aquatic animals and dung-feeding insects, but specifically states they are not toxic to birds.

Q: What is the primary reason for the combination of ivermectin and doxycycline in heartworm treatment?
a. To increase the speed of microfilariae clearance
b. To reduce the risk of anaphylaxis
c. To eliminate Wolbachia endosymbionts and reduce host antigenic response
d. To prevent resistance development
e. To enhance penetration of the blood-brain barrier
A: c. To eliminate Wolbachia endosymbionts and reduce host antigenic response. The text explains that the combination of ivermectin and doxycycline is used to eliminate Wolbachia bacteria, which are endosymbionts necessary for heartworm survival, thereby decreasing the host antigenic response.

Q: Which macrocyclic lactone is FDA-approved for cats as both an ear mite treatment and a heartworm preventive?
a. Moxidectin
b. Selamectin
c. Milbemycin oxime
d. Ivermectin
e. Eprinomectin
A: d. Ivermectin. The text states that ivermectin is approved for cats as an ear mite treatment (ACAREXX OTIC SUSPENSION) and as a heartworm preventive (HEARTGARD CHEWABLES FOR CATS).

Q: Which macrocyclic lactone has the longest elimination half-life in dogs?
a. Ivermectin
b. Selamectin
c. Moxidectin
d. Milbemycin oxime
e. Doramectin
A: c. Moxidectin. The text mentions that in dogs, the half-life of ivermectin is 2 days while the half-life of moxidectin is 19 days.

Q: What is the unique feature of EPRINEX POUR-ON FOR BEEF and DAIRY CATTLE regarding withdrawal time?
a. 21-day withdrawal for meat
b. 35-day withdrawal for milk
c. 48-hour withdrawal for meat and milk
d. Zero withdrawal time for meat and milk
e. 7-day withdrawal for meat, zero for milk
A: d. Zero withdrawal time for meat and milk. The text states that eprinomectin pour-on has zero time withdrawal for meat and milk.

Q: Which of the following is NOT an FDA-approved use for selamectin in dogs?
a. Prevention of heartworm disease
b. Control of fleas
c. Treatment of ear mites
d. Control of sarcoptic mange
e. Treatment of demodectic mange
A: e. Treatment of demodectic mange. The text specifically mentions that selamectin has not been effective in treating demodectic mange, while all other options are listed as approved uses.

Q: What is the mechanism by which macrocyclic lactones affect nematodes and arthropods?
a. Inhibition of acetylcholinesterase
b. Blockade of GABA-gated chloride channels
c. Disruption of cell membrane integrity
d. Inhibition of protein synthesis
e. Binding to glutamate-gated chloride channels
A: e. Binding to glutamate-gated chloride channels. The text states that macrocyclic lactones bind with high affinity to glutamate-gated chloride channels, triggering chloride influx, hyperpolarization, paralysis, and death.

Q: Which macrocyclic lactone is uniquely effective in preventing Ancylostoma caninum in dams and pups when given at 1 mg/kg SC on pregnancy day 55?
a. Ivermectin
b. Selamectin
c. Moxidectin
d. Milbemycin oxime
e. Doramectin
A: c. Moxidectin. The text specifically states that moxidectin is the only drug with 100% efficacy in preventing Ancylostoma caninum in dams and pups when given at this dose and timing.

Q: What is the primary reason for the development of the Risk Minimization Action Plan (RiskMAP) for PROHEART 6?
a. To prevent off-label use
b. To address FDA safety concerns due to adverse event reports
c. To increase market share
d. To comply with new regulations
e. To reduce manufacturing costs
A: b. To address FDA safety concerns due to adverse event reports. The text mentions that PROHEART 6 was reintroduced to the US market under a RiskMAP to address ongoing FDA safety concerns resulting from adverse event reports.

Q: Which of the following is NOT a typical sign of ivermectin toxicity in dogs?
a. Vomiting
b. Ataxia
c. Mydriasis
d. Hyperthermia
e. Bradycardia
A: d. Hyperthermia. While hyperthermia is not listed among the typical signs of ivermectin toxicity in dogs, all other options are mentioned in the text.

Q: What is the approved dose of milbemycin oxime for heartworm prevention in dogs?
a. 0.05 mg/kg monthly
b. 0.1 mg/kg monthly
c. 0.5 mg/kg monthly
d. 1 mg/kg monthly
e. 2 mg/kg monthly
A: c. 0.5 mg/kg monthly. The text states that milbemycin oxime tablets are formulated to deliver 0.5 mg/kg to dogs for heartworm prevention.

Q: Which macrocyclic lactone is FDA-approved for use in American bison and reindeer?
a. Moxidectin
b. Doramectin
c. Eprinomectin
d. Ivermectin
e. Selamectin
A: d. Ivermectin. The text mentions that the FDA has approved ivermectin injection for use in American bison and reindeer for specific parasites.

Q: What is the primary reason for caution when using macrocyclic lactones to treat cattle grubs (Hypoderma spp. larvae)?
a. Inefficacy against this parasite
b. Risk of anaphylaxis in cattle
c. Potential for bloat or paralysis if many larvae are present
d. Rapid development of resistance
e. Prolonged meat withdrawal times
A: c. Potential for bloat or paralysis if many larvae are present. The text warns that treatment of cattle grubs with macrocyclic lactones can result in bloat or paralysis if many larvae are present in the gullet or vertebral canal.

Q: Which of the following is TRUE regarding the use of ivermectin in pregnant animals?
a. It is contraindicated in all species
b. It causes teratogenesis in cattle, sheep, and dogs
c. It is safe at 4× the recommended dose in cattle, sheep, and dogs
d. It causes fetal malformations at all doses
e. It is only safe in the first trimester
A: c. It is safe at 4× the recommended dose in cattle, sheep, and dogs. The text states that no teratogenesis was noted in cattle, sheep, and dogs when ivermectin was administered to pregnant animals at 4× the recommended dose.

Q: What is the unique feature of milbemycin oxime regarding its safety in Collies?
a. It is equally toxic as ivermectin
b. It is safe at up to 20× the recommended dose
c. It cannot be used in Collies at any dose
d. It requires genetic testing before use
e. It is only safe when given orally
A: b. It is safe at up to 20× the recommended dose. The text mentions that milbemycin oxime is nontoxic to rough-coated Collies at up to 20× the recommended dose.

Q: Which macrocyclic lactone is available as a sustained-release injection for cattle, providing up to 150 days of persistent effectiveness against certain parasites?
a. Ivermectin
b. Doramectin
c. Moxidectin
d. Eprinomectin
e. Selamectin
A: d. Eprinomectin. The text describes eprinomectin injectable (LONGRANGE) as providing up to 150-day-persistent effectiveness against certain parasites in cattle.

Q: What is the primary concern regarding the use of macrocyclic lactones in heartworm prevention?
a. Lack of efficacy against adult worms
b. High cost of treatment
c. Frequent dosing requirements
d. Development of resistance in some heartworm strains
e. Severe side effects in all breeds
A: d. Development of resistance in some heartworm strains. The text mentions that a serious issue has arisen related to potential resistance, with several strains of heartworm becoming resistant to the normal preventative dose of macrocyclic lactones.

Q: Which of the following is NOT a typical use of selamectin in cats?
a. Prevention of heartworm disease
b. Control of fleas
c. Treatment of ear mites
d. Control of roundworms
e. Treatment of tapeworms
A: e. Treatment of tapeworms. While the text lists prevention of heartworm disease, control of fleas, treatment of ear mites, and control of roundworms as approved uses for selamectin in cats, it does not mention treatment of tapeworms.